Abstract | BACKGROUND: METHODS: This was a cohort study of five months' duration (August-December 2008) conducted at the Yaoundé General Hospital's hemodialysis center, involving 95 patients (67 men, 70.5%) on chronic hemodialysis by a native arteriovenous fistula. A monthly evaluation included full blood counts, number of pints of red cell concentrates transfused, and vital status. RESULTS: At baseline, 75 (79%) patients had anemia which was microcytic and hypochromic in 32 (43%). Anemia was corrected in 67 (70.5%) patients using blood transfusion only, while 28 (29.5%) patients were receiving erythropoietin (11 regularly, 39%). Only 77.2% of 342 pints (median 3.0, range 0-17 per patients) of red cell concentrates prescribed were effectively received during the follow-up at an unacceptably high cost to patients and families. Mean hemoglobin and mean corpuscular hemoglobin levels remained stable during follow-up, while mean corpuscular volume increased. Erythropoietin treatment was the main determinant of favorable trajectories of hematological markers. CONCLUSIONS:
|
Authors | Francois Folefack Kaze, Andre-Pascal Kengne, Alex Tatang Mambap, Marie-Patrice Halle, Dora Mbanya, Gloria Ashuntantang |
Journal | African health sciences
(Afr Health Sci)
Vol. 15
Issue 1
Pg. 253-60
(Mar 2015)
ISSN: 1729-0503 [Electronic] Uganda |
PMID | 25834556
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aged
- Anemia, Hypochromic
(epidemiology, etiology, therapy)
- Blood Transfusion
- Cameroon
(epidemiology)
- Disease Management
- Female
- Follow-Up Studies
- Hemoglobins
(metabolism)
- Humans
- Kidney Failure, Chronic
(complications, epidemiology, therapy)
- Male
- Middle Aged
- Prevalence
- Prospective Studies
- Renal Dialysis
(adverse effects)
- Treatment Outcome
- Young Adult
|